Pathophysiology and treatment of focal cerebral ischemia

Journal of Neurosurgery - Tập 77 Số 2 - Trang 169-184 - 1992
Bo K. Siesjö1
1Laboratory for Experimental Brain Research, Lund University Hospital, Sweden

Tóm tắt

✓ This article examines the pathophysiology of lesions caused by focal cerebral ischemia. Ischemia due to middle cerebral artery occlusion encompasses a densely ischemic focus and a less densely ischemic penumbral zone. Cells in the focus are usually doomed unless reperfusion is quickly instituted. In contrast, although the penumbra contains cells “at risk.” these may remain viable for at least 4 to 8 hours. Cells in the penumbra may be salvaged by reperfusion or by drugs that prevent an extension of the infarction into the penumbral zone. Factors responsible for such an extension probably include acidosis, edema, K+/Ca++transients, and inhibition of protein synthesis.

Central to any discussion of the pathophysiology of ischemic lesions is energy depletion. This is because failure to maintain cellular adenosine triphosphate (ATP) levels leads to degradation of macromolecules of key importance to membrane and cytoskeletal integrity, to loss of ion homeostasis, involving cellular accumulation of Ca++, Na+, and Cl−, with osmotically obligated water, and to production of metabolic acids with a resulting decrease in intra- and extracellular pH.

In all probability, loss of cellular calcium homeostasis plays an important role in the pathogenesis of ischemic cell damage. The resulting rise in the free cytosolic intracellular calcium concentration (Ca++) depends on both the loss of calcium pump function (due to ATP depletion), and the rise in membrane permeability to calcium. In ischemia, calcium influx occurs via multiple pathways. Some of the most important routes depend on activation of receptors by glutamate and associated excitatory amino acids released from depolarized presynaptic endings. However, ischemia also interferes with the intracellular sequestration and binding of calcium, thereby contributing to the rise in intracellular Ca++.

A second key event in the ischemic tissue is activation of anaerobic glucolysis. The main reason for this activation is inhibition of mitochondrial metabolism by lack of oxygen; however, other factors probably contribute. For example, there is a complex interplay between loss of cellular calcium homeostasis and acidosis. On the one hand, a rise in intracellular Ca++is apt to cause mitochondrial accumulation of calcium. This must interfere with ATP production and enhance anaerobic glucolysis. On the other hand, acidosis must interfere with calcium binding, thereby contributing to the rise in intracellular Ca++.

Từ khóa


Tài liệu tham khảo

Anderson RE, 1983, J Cereb Blood Flow Metab, 3, 493, 10.1038/jcbfm.1983.76

Astrup J, 1981, Stroke, 12, 723, 10.1161/01.STR.12.6.723

Astrup J, 1977, Stroke, 8, 51, 10.1161/01.STR.8.1.51

Bazan N, 1990, Pharmacology of Cerebral Ischemia., 391

10.1007/BF02536539

Bazan NG, 1976, Adv Exp Med Biol, 72, 317, 10.1007/978-1-4684-0955-0_26

Behar KL, 1989, J Cereb Blood Flow Metab, 9, 655, 10.1038/jcbfm.1989.93

Ben-An Y, 1990, Trends Neurosci, 13, 409

Ben-Ari Y, 1990, Neuroscience, 37, 55, 10.1016/0306-4522(90)90191-6

Berridge MJ, 1984, Biochem J, 220, 345, 10.1042/bj2200345

10.1146/annurev.bi.56.070187.001111

Blaustein MP, 1988, Trends Neurosci, 11, 438, 10.1016/0166-2236(88)90195-6

Bolander HG, 1989, Stroke, 20, 930, 10.1161/01.STR.20.7.930

Bolas N, 1988, Stroke, 19, 608, 10.1161/01.STR.19.5.608

Branston NM, 1977, J Neurol Sci, 32, 305, 10.1016/0022-510X(77)90014-4

Branston NM, 1974, Exp Neurol, 45, 195, 10.1016/0014-4886(74)90112-5

Brierley JB, 1984, Greenfield's Neuropathology, 4, 125

Carafoli E, 1987, Annu Rev Biochem, 56, 395, 10.1146/annurev.bi.56.070187.002143

Choi D, 1990, Cerebrovasc Brain Metab Rev, 2, 105

Chopp M, 1987, Stroke, 18, 919, 10.1161/01.STR.18.5.919

Chopp M, 1988, Stroke, 19, 1383, 10.1161/01.STR.19.11.1383

Cotman C, 1989, Ann NY Acad Sci, 568, 138, 10.1111/j.1749-6632.1989.tb12501.x

Crowell R, 1981, Neurology, 31, 1295, 10.1212/WNL.31.10.1295

Crowell RM, 1970, Stroke, 1, 439, 10.1161/01.STR.1.6.439

DeGirolami U, 1984, J Neuropathol Exp Neurol, 43, 57, 10.1097/00005072-198401000-00005

Duchen MR, 1990, J Physiol (Lond), 424, 387, 10.1113/jphysiol.1990.sp018073

Eisner DA, 1985, Am J Physiol, 248, C189, 10.1152/ajpcell.1985.248.3.C189

Fagg GE, 1986, Trends Pharmacol Sci, 7, 357, 10.1016/0165-6147(86)90386-X

Flamm ES, 1978, Stroke, 9, 445, 10.1161/01.STR.9.5.445

Folbergrová J, 1990, J Neurochem, 55, 1690, 10.1111/j.1471-4159.1990.tb04957.x

Frandsen A, 1991, J Neurochem, 56, 1075, 10.1111/j.1471-4159.1991.tb02031.x

Garcia J, 1984, Stroke, 15, 5, 10.1161/01.STR.15.1.5

Gardiner M, 1982, J Cereb Blood Flow Metab, 2, 429, 10.1038/jcbfm.1982.49

Ginsberg MD, 1989, Stroke, 20, 1627, 10.1161/01.STR.20.12.1627

Ginsberg MD, 1976, Stroke, 7, 125, 10.1161/01.STR.7.2.125

Glaum SR, 1990, J Pharmacol Exp Ther, 253, 1293

Greenberg D, 1987, Ann Neurol, 21, 317, 10.1002/ana.410210402

Hakim AM, 1986, J Cereb Blood Flow Metab, 6, 676, 10.1038/jcbfm.1986.123

Hakim AM, 1987, Can J Neurol Sci, 14, 557

Hansen AJ, 1985, Physiol Rev, 65, 101, 10.1152/physrev.1985.65.1.101

Hansen AJ, 1981, Acta Physiol Scand, 113, 437, 10.1111/j.1748-1716.1981.tb06920.x

Harris RJ, 1984, J Cereb Blood Flow Metab, 4, 178, 10.1038/jcbfm.1984.26

Harris RJ, 1981, J Cereb Blood Flow Metab, 1, 203, 10.1038/jcbfm.1981.21

Heiss WD, 1976, Arch Neurol, 33, 813, 10.1001/archneur.1976.00500120017003

10.1002/ana.410140307

Hochachka PW, 1983, Science, 219, 1391, 10.1126/science.6298937

Hossmann KA, 1985, Prog Brain Res, 63, 3, 10.1016/S0079-6123(08)61971-8

Hossmann KA, 1973, Arch Neurol, 29, 375, 10.1001/archneur.1973.00490300037004

Hossmann KA, 1977, Stroke, 8, 77, 10.1161/01.STR.8.1.77

Ito U, 1979, Stroke, 10, 542, 10.1161/01.STR.10.5.542

Jacewicz M, 1990, J Cereb Blood Flow Metab, 10, 89, 10.1038/jcbfm.1990.11

Johshita H, 1989, Stroke, 20, 788, 10.1161/01.STR.20.6.788

10.3171/jns.1981.54.6.0773

Kaila K, 1987, Nature, 330, 163, 10.1038/330163a0

Kanner BI, 1987, CRC Crit Rev Biochem, 22, 1, 10.3109/10409238709082546

Kaplan B, 1991, Stroke, 22, 1032, 10.1161/01.STR.22.8.1032

Kobataka K, 1984, Stroke, 15, 540, 10.1161/01.STR.15.3.540

10.3995/jstroke.8.1

Kontos HA, 1985, Circ Res, 57, 508, 10.1161/01.RES.57.4.508

Korthuis RJ, 1985, Circ Res, 57, 599, 10.1161/01.RES.57.4.599

Kraig RP, 1978, Neuroscience, 3, 1045, 10.1016/0306-4522(78)90122-7

Krieglstein J, 1990, Pharmacology of Cerebral Ischemia.

Krnjević K, 1987, Can J Physiol Pharmacol, 65, 2157, 10.1139/y87-340

Lazdunski M, 1985, J Mol Cell Cardiol, 17, 1029, 10.1016/S0022-2828(85)80119-X

Leblanc R, 1991, Curr Opin Neurol Neurosurg, 4, 63

Lemasters JJ, 1987, Nature, 325, 78, 10.1038/325078a0

10.1016/0006-8993(74)90782-3

Lodge D, 1990, Trends Pharmacol Sci, 11, 21

10.1161/01.STR.20.1.84

Marcoux FW, 1982, Stroke, 13, 339, 10.1161/01.STR.13.3.339

Marrannes R, 1988, Brain Res, 457, 226, 10.1016/0006-8993(88)90690-7

Mayer ML, 1987, Prog Neurobiol, 28, 197, 10.1016/0301-0082(87)90011-6

Mayer ML, 1984, Nature, 309, 261, 10.1038/309261a0

McBurney RN, 1987, Trends Neurosci, 10, 164, 10.1016/0166-2236(87)90042-7

McCord JM, 1985, N Engl J Med, 312, 159, 10.1056/NEJM198501173120305

Memezawa H, Exp Brain Res

Memezawa H, 1992, Stroke, 23, 552, 10.1161/01.STR.23.4.552

Meyer FB, 1990, J Cereb Blood Flow Metab, 10, 97, 10.1038/jcbfm.1990.12

10.3171/jns.1986.64.4.0617

10.1016/S0025-6196(12)61523-7

Michenfelder JD, 1971, Stroke, 5, 319, 10.1161/01.STR.2.4.319

Michenfelder JD, 1970, Anesthesiology, 33, 430, 10.1097/00000542-197010000-00013

Mies G, 1983, Stroke, 14, 22, 10.1161/01.STR.14.1.22

Mies G, 1991, J Cereb Blood Flow Metab, 11, 753, 10.1038/jcbfm.1991.132

Miller RJ, 1987, Science, 235, 46, 10.1126/science.2432656

Molinari GF, 1976, Stroke, 7, 14, 10.1161/01.STR.7.1.14

Mourre C, 1989, Brain Res, 486, 159, 10.1016/0006-8993(89)91288-2

Murphy SN, 1988, Proc Natl Acad Sci USA, 85, 8737, 10.1073/pnas.85.22.8737

Mutch WA, 1984, J Cereb Blood Flow Metab, 4, 17, 10.1038/jcbfm.1984.3

Nagasawa H, 1989, Stroke, 20, 1037, 10.1161/01.STR.20.8.1037

Nahorski S, 1988, Trends Neurosci, 11, 444, 10.1016/0166-2236(88)90196-8

Nakai H, 1988, Stroke, 19, 764, 10.1161/01.STR.19.6.764

Naritomi H, 1988, J Cereb Blood Flow Metab, 8, 16, 10.1038/jcbfm.1988.3

Nedergaard M, 1987, Acta Neuropathol, 73, 267, 10.1007/BF00686621

Nedergaard M, 1987, Brain Res, 408, 79, 10.1016/0006-8993(87)90360-X

Nedergaard M, 1987, Acta Neuropathol, 73, 131, 10.1007/BF00693778

Nedergaard M, 1986, J Cereb Blood Flow Metab, 6, 414, 10.1038/jcbfm.1986.74

Nedergaard M, 1986, Stroke, 17, 1129, 10.1161/01.STR.17.6.1129

Nicholls D, 1990, Trends Pharmacol Sci, 11, 462, 10.1016/0165-6147(90)90129-V

Nicholson C, 1977, Proc Natl Acad Sci USA, 74, 1287, 10.1073/pnas.74.3.1287

Nicoletti F, 1986, J Neurosci, 6, 1905, 10.1523/JNEUROSCI.06-07-01905.1986

10.1111/j.1748-1716.1978.tb06279.x

Nowak L, 1984, Nature, 307, 462, 10.1038/307462a0

Obrenovitch T, 1990, J Neurophysiol, 64, 1125, 10.1152/jn.1990.64.4.1125

Obrenovitch TP, 1988, J Cereb Blood Flow Metab, 8, 866, 10.1038/jcbfm.1988.144

10.1136/bmj.298.6674.636

Reichardt LF, 1983, Annu Rev Biochem, 52, 871, 10.1146/annurev.bi.52.070183.004255

Ritchie J, 1986, Ion Channels in Neural Membranes.

10.1002/ana.410190202

Sako K, 1985, Stroke, 16, 828, 10.1161/01.STR.16.5.828

Sanchez-Armass S, 1987, Am J Physiol, 252, C595, 10.1152/ajpcell.1987.252.6.C595

Sharbrough FW, 1973, Stroke, 4, 674, 10.1161/01.STR.4.4.674

Siesjö B, 1978, Brain Energy Metabolism.

Siesjö B, 1990, News Physiol Sci, 5, 120

Siesjö B, 1992, Neurodegenerative Disorders: Mechanisms and Prospects for Therapy., 35

Siesjö B, 1990, Pharmacology of Cerebral Ischemia., 319

Siesjö BK, 1988, Neurochem Pathol, 9, 31, 10.1007/BF03160355

Siesjö BK, 1990, Eur Neurol, 30, 3, 10.1159/000117184

Siesjö BK, 1981, J Cereb Blood Flow Metab, 1, 155, 10.1038/jcbfm.1981.18

10.3171/jns.1984.60.5.0883

10.1111/j.1749-6632.1988.tb33410.x

Siesjö BK, 1988, Crit Care Med, 16, 954, 10.1097/00003246-198810000-00006

Siesjö BK, J Neurosurg, 77

Siesjö BK, 1989, Cerebrovasc Brain Metab Rev, 1, 165

Siesjö BK, 1989, J Cereb Blood Flow Metab, 9, 127, 10.1038/jcbfm.1989.20

Siesjö BK, 1989, Ann NY Acad Sci, 568, 234, 10.1111/j.1749-6632.1989.tb12513.x

Siesjö BK, 1971, Scand J Clin Lab Invest, 27, 83, 10.3109/00365517109080193

Siesjö BK, 1970, Acta Physiol Scand, 79, 114, 10.1111/j.1748-1716.1970.tb04707.x

Silver IA, 1990, J Gen Physiol, 95, 837, 10.1085/jgp.95.5.837

Sladeczek F, 1988, Trends Neurosci, 11, 545, 10.1016/0166-2236(88)90183-X

10.1007/BF00690397

Smith ML, 1986, J Cereb Blood Flow Metab, 6, 574, 10.1038/jcbfm.1986.104

Strong AJ, 1984, Stroke, 15, 755, 10.1161/01.STR.15.1.180

Strong AJ, 1983, J Cereb Blood Flow Metab, 3, 97, 10.1038/jcbfm.1983.12

Strong AJ, 1983, J Cereb Blood Flow Metab, 3, 86, 10.1038/jcbfm.1983.11

Sugiyama H, 1987, Nature, 325, 531, 10.1038/325531a0

10.3171/jns.1969.31.3.0311

Sundt TM, 1972, Circ Res, 30, 703, 10.1161/01.RES.30.6.703

Symon L, 1979, Stroke, 10, 184, 10.1161/01.STR.10.2.184

Symon L, 1976, Stroke, 7, 547, 10.1161/01.STR.7.6.547

Symon L, 1974, Stroke, 5, 355, 10.1161/01.STR.5.3.355

Tamura A, 1980, Stroke, 11, 487, 10.1161/01.STR.11.5.487

Tamura A, 1981, J Cereb Blood Flow Metab, 1, 61, 10.1038/jcbfm.1981.7

Trojaborg W, 1973, Electroencephalogr Clin Neurophysiol, 34, 61, 10.1016/0013-4694(73)90151-X

Tsien RW, 1988, Trends Neurosci, 11, 431, 10.1016/0166-2236(88)90194-4

Tyson GW, 1984, Ann Neurol, 15, 559, 10.1002/ana.410150608

Uematsu D, 1988, J Cereb Blood Flow Metab, 8, 367, 10.1038/jcbfm.1988.72

von Hanwehr R, 1986, J Neurochem, 46, 331, 10.1111/j.1471-4159.1986.tb12973.x

Vyskočil F, 1972, Brain Res, 39, 255, 10.1016/0006-8993(72)90802-5

Waltz AG, 1968, Neurology, 18, 613, 10.1212/WNL.18.7.613

Watkins JC, 1981, Annu Rev Pharmacol Toxicol, 21, 165, 10.1146/annurev.pa.21.040181.001121

Watkins JC, 1987, Trends Neurosci, 10, 265, 10.1016/0166-2236(87)90171-8

Weinstein PR, 1986, Stroke, 17, 318, 10.1161/01.STR.17.2.318

Westenbroek RE, 1990, Nature, 347, 281, 10.1038/347281a0

Wiebers DO, 1990, Stroke, 21, 1, 10.1161/01.STR.21.1.1

Wieloch T, 1984, J Neurochem, 43, 160, 10.1111/j.1471-4159.1984.tb06692.x

Wieloch T, 1982, Pathol Biol, 30, 269

Xie Y, 1989, Stroke, 20, 620, 10.1161/01.STR.20.5.620

Thông tin
Thông tin xuất bản

Journal of Neurosurgery

Tập 77 Số 2

169-184

Thông tin tác giả